Live Sessions
Recorded Sessions

ESCEO Symposia

Determinants of the differences between the ESCEO and OARSI 2019 guidelines for the management of knee osteoarthritis
Chairpersons: Ali Mobasheri, Jean Yves Reginster
‣ Similarities and differences between the OARSI and ESCEO guidelines for the management of knee osteoarthritis - Ravi Bannuru
‣ How can we explain the differences between the OARSI and ESCEO guidelines for the management of knee osteoarthritis? - Nigel K. Arden
‣ Closing remarks - Olivier Bruyère


Update of the ESCEO recommendations for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia
Chairpersons: Charlotte Beaudart, Roger A. Fielding
‣ Introduction - Alfonso Cruz Jentoft
‣ Patients to be included in clinical trials assessing the safety and efficacy of new chemical entities aiming at the treatment of sarcopenia - Mario Miguel Rosa
‣ Primary and secondary endpoints for clinical trials assessing the safety and efficacy of new chemical entities aiming at the treatment of sarcopenia - Andrea Laslop
‣ Closing remarks - Jürgen Bauer and Andrea Trombetti